Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
The American Society of Clinical Oncology annual meeting in Chicago last year. One of the conference’s coveted headliners this year will be a presentation of a clinical trial conducted only in China.
A Dominion Energy power plant near Davis, W.Va. NextEra Energy’s political activities are expected to be scrutinized as it seeks approval of its purchase of Dominion.
The TV network slammed the Federal Communications Commission, saying the regulator was targeting its station licenses in a campaign of “unconstitutional retaliation.”
The filing was the second time this month that ABC accused the Federal Communications Commission of violating its free speech rights because of what the network has called “speech the government does not like.”
China’s tobacco monopoly has become so financially vital to the government that even its powerful leader has failed to curb the country’s smoking habit.
Backlash to artificial intelligence is here, and digital natives are leading the charge. The Opinion columnist Michelle Goldberg argues that the A.I. pessimism in America stems from a lack of responsible regulation.
The leaders of both countries are expected to discuss the risks from artificial intelligence, but neither country is willing to be the first to slow down.
The war in Iran has disrupted supplies of diesel, used to power trucks and heavy equipment, much more than gasoline, which is primarily used in passenger cars.